95 related articles for article (PubMed ID: 9615269)
1. Differences in Mucosal Permeability Among Patients With Ulcerative Colitis Classified Based on the Colonic Location and Disease Activity.
Shiratori W; Ohta Y; Matsusaka K; Ohyama Y; Mamiya Y; Nakazawa H; Takahashi S; Horio R; Goto C; Sonoda M; Kurosugi A; Kaneko T; Akizue N; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Shiko Y; Ozawa Y; Kato J; Ikeda J; Kato N
Clin Transl Gastroenterol; 2024 May; 15(5):e00692. PubMed ID: 38363861
[TBL] [Abstract][Full Text] [Related]
2. Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis.
McBride RB; Suarez-Farinas M; Ko HM; Chen X; Liu Q; Harpaz N
Inflamm Bowel Dis; 2023 Nov; 29(11):1706-1712. PubMed ID: 37075483
[TBL] [Abstract][Full Text] [Related]
3.
Ding H; Dupont AW; Singhal S; Scott LD; Guha S; Younes M; Bi X
Biomed Opt Express; 2017 Jul; 8(7):3426-3439. PubMed ID: 28717578
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide substance P and the immune response.
Mashaghi A; Marmalidou A; Tehrani M; Grace PM; Pothoulakis C; Dana R
Cell Mol Life Sci; 2016 Nov; 73(22):4249-4264. PubMed ID: 27314883
[TBL] [Abstract][Full Text] [Related]
5. The Microbiota Conducts the Vasoactive Intestinal Polypeptide Orchestra in the Small Intestine.
Gonzales J; Gulbransen BD
Cell Mol Gastroenterol Hepatol; 2024; 17(3):503-504. PubMed ID: 38109941
[No Abstract] [Full Text] [Related]
6. Treatment of ulcerative colitis with intestinal mucosa.
Gill AM
Proc R Soc Med; 1946 Jul; 39(9):517-9. PubMed ID: 19993345
[No Abstract] [Full Text] [Related]
7. P2Y
Zuo YQ; Tang Y
Purinergic Signal; 2024 May; ():. PubMed ID: 38722454
[No Abstract] [Full Text] [Related]
8. Advances in molecular markers for diagnosis of ulcerative colitis.
Wu C; Song R; Xu H; Li X; Xie J
Minerva Med; 2024 May; ():. PubMed ID: 38752690
[No Abstract] [Full Text] [Related]
9. Role of Substance P in the Pathophysiology of Inflammatory Bowel Disease and Its Correlation With the Degree of Inflammation.
Patel M; Valaiyaduppu Subas S; Ghani MR; Busa V; Dardeir A; Marudhai S; Cancarevic I
Cureus; 2020 Oct; 12(10):e11027. PubMed ID: 33214955
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice.
Abad C; Tan YV
J Mol Neurosci; 2018 Sep; 66(1):102-113. PubMed ID: 30105629
[TBL] [Abstract][Full Text] [Related]
11. Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.
Sargın ZG; Erin N; Tazegul G; Elpek GÖ; Yıldırım B
PLoS One; 2017; 12(12):e0189526. PubMed ID: 29232715
[TBL] [Abstract][Full Text] [Related]
12. The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease.
Di Giovangiulio M; Verheijden S; Bosmans G; Stakenborg N; Boeckxstaens GE; Matteoli G
Front Immunol; 2015; 6():590. PubMed ID: 26635804
[TBL] [Abstract][Full Text] [Related]
13. Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant.
Szitter I; Pintér E; Perkecz A; Kemény A; Kun J; Kereskai L; Pietra C; Quinn JP; Zimmer A; Berger A; Paige CJ; Helyes Z
Inflamm Res; 2014 May; 63(5):399-409. PubMed ID: 24468892
[TBL] [Abstract][Full Text] [Related]
14. Involvement of primary afferent nerves after abdominal irradiation: consequences on ileal contractile activity and inflammatory mediator release in the rat.
Linard C; Marquette C; Strup C; Aigueperse J; Mathe D
Dig Dis Sci; 2003 Apr; 48(4):688-97. PubMed ID: 12741457
[TBL] [Abstract][Full Text] [Related]
15. Changes in chemical coding of myenteric neurones in ulcerative colitis.
Neunlist M; Aubert P; Toquet C; Oreshkova T; Barouk J; Lehur PA; Schemann M; Galmiche JP
Gut; 2003 Jan; 52(1):84-90. PubMed ID: 12477766
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.
Lee CM; Kumar RK; Lubowski DZ; Burcher E
Dig Dis Sci; 2002 Mar; 47(3):495-502. PubMed ID: 11913410
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine changes in colon of mice with a disrupted IL-2 gene.
Qian BF; El-Salhy M; Melgar S; Hammarström ML; Danielsson A
Clin Exp Immunol; 2000 Jun; 120(3):424-33. PubMed ID: 10844519
[TBL] [Abstract][Full Text] [Related]
18. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
19. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
